Transcription factor | Type of interaction | Effects of interaction with glucocorticoid receptor | Refs |
---|---|---|---|
AP-1 | Tethering | AP-1 inhibited | 124 |
C/EBPβ | Composite | C/EBPβ inhibited | 125 |
CREB | Composite | Enhanced CREB2 activity | 126 |
ETS2 | Composite | Enhanced ETS2 activity | 127 |
GATA1 | Composite | GATA1 inhibited | 128 |
NF-κB | Tethering | NF-κB inhibited | 129 |
NR4A1 | Tethering | NR4A1 inhibited | 130 |
POU2F1 | Tethering | POU2F1 inhibited | 131 |
SMAD3 | Tethering | SMAD3 inhibited | 132 |
STAT3 | Tethering | Enhanced STAT3 activity | 133 |
STAT5 | Tethering | Enhanced STAT5 activity | 134 |
STAT6 | Tethering | STAT6 inhibited | 135 |
T-bet | Tethering | T-bet inhibited | 82 |
AP-1, activator protein 1; C/EBPβ, CCAAT/enhancer-binding protein-β; CREB, cAMP-responsive element-binding protein; GATA1, GATA-binding factor 1 (also known as erythroid transcription factor); NF-κB, nuclear factor-κB; NR4A1, nuclear receptor subfamily 4 group A member 1 (also known as NUR77); POU2F1, POU domain class 2 transcription factor 1 (also known as OCT1); SMAD3, mothers against decapentaplegic homologue 3; STAT, signal transducer and activator of transcription.